Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder (NCT07123467)
Cannabidiol-Enhanced Cognitive Behavioral Therapy for Generalized Anxiety Disorder
🩺 Plain-English Summary (8th-Grade Level)
This randomized, double-blind, placebo-controlled clinical trial investigates the use of Food and Drug Administration (FDA)-approved cannabidiol (EPIDIOLEX®) as an adjunct to cognitive behavioral therapy (CBT) in adults with generalized anxiety disorder (GAD). The study aims to evaluate whether cannabidiol-assisted CBT enhances emotion regulation via dorsomedial prefrontal cortex (dmPFC) activation and improves anxiety symptom outcomes compared to CBT with placebo.
Who can join: Review the eligibility criteria below.
Location: Wayne State University School of Medicine, Tolan Park Medical Building — Detroit, Michigan
Age range: 18 Years to 45 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Wayne State University School of Medicine, Tolan Park Medical Building — Detroit, Michigan
📞 Contact the Study Coordinator
Phone: (313) 577-1278
Email: hmarusak@med.wayne.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Generalized Anxiety Disorder (GAD)
- Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder — Huntsville, Alabama
- Stepped Care Treatment for Anxiety Resilience — Houston, Texas
- Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder — Kingston, Ontario
- Personalized AI-Driven Models in Cognitive Behavioral Therapy for Anxiety — Los Angeles, California
- Text Message Safety Behavior Fading for Pathological Worry — Tallahassee, Florida
Explore by condition: All Generalized Anxiety Disorder (GAD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.